Opus Genetics (IRD) Change in Acquisitions & Divestments (2011 - 2020)

Opus Genetics (IRD) has reported Change in Acquisitions & Divestments for 8 consecutive years, with $3.0 million the latest figure, recorded in Q1 2020.

• In Q1 2020, Change in Acquisitions & Divestments changed 0.0% year-over-year to $3.0 million; the TTM figure through Sep 2020 stood at $6.0 million (down 45.45% YoY), while the FY2019 annual figure was $12.0 million, changed 0.42% from the prior year.
• Change in Acquisitions & Divestments steadied at $3.0 million in Q1 2020 per IRD's latest filing, from $3.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $5.1 million in Q3 2016 and bottomed at $960000.0 in Q1 2016.
• Historically, Change in Acquisitions & Divestments has averaged $3.1 million across 5 years, with a median of $3.0 million in 2017.
• Annual changes were most pronounced in 2016 — Change in Acquisitions & Divestments sank 80.74% — and 2017, when it soared 183.33%.
• Opus Genetics' Change in Acquisitions & Divestments stood at $4.7 million in 2016, then tumbled by 35.9% to $3.0 million in 2017, then plunged by 33.33% to $2.0 million in 2018, then jumped by 50.0% to $3.0 million in 2019, then changed by 0.0% to $3.0 million in 2020.
• Business Quant data shows IRD's Change in Acquisitions & Divestments at $3.0 million in Q1 2020, $3.0 million in Q4 2019, and $3.0 million in Q3 2019.